Azithromycin Prices In USA                               

  • United States: 122750 USD/MT (Azithromycin Dihydrate) US, FDA

The azithromycin prices in the USA for Q4 2023 reached 1,22,750 USD/MT in December. 

The latest report by IMARC Group, titled "Azithromycin Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data," provides a thorough examination of the Azithromycin Prices. This report delves into the price of Azithromycin globally, presenting a detailed analysis, along with informative Price Chart. Through comprehensive Price analysis, the report sheds light on the key factors influencing these trend. Additionally, it includes historical data to offer context and depth to the current pricing landscape. The report also explores the Demand, analyzing how it impacts Industry dynamics. To aid in strategic planning, the price forecast section provides insights into price forecast, making this report an invaluable resource for industry stakeholders.


Azithromycin Prices Analysis

  • China: 120000 USD/MT (Azithromycin Dihydrate) US, FDA
  • Germany: 122195 USD/MT (Azithromycin Dihydrate) US, FDA

Report Offering:

  • Monthly Updates - Annual Subscription
  • Quarterly Updates - Annual Subscription
  • Biannually Updates - Annual Subscription

The study delves into the factors affecting Azithromycin price variations, including alterations in the cost of raw materials, the balance of supply and demand, geopolitical influences, and sector-specific developments.

The report also incorporates the most recent updates from the market, equipping stakeholders with the latest information on market fluctuations, regulatory modifications, and technological progress. It serves as an exhaustive resource for stakeholders, enhancing strategic planning and forecast capabilities.

Request For a Sample Copy of the Report:  https://www.imarcgroup.com/azithromycin-pricing-report/requestsample

Azithromycin Price Trend-  Last Quarter

The azithromycin market is primarily driven by its broad-spectrum application in treating bacterial infections, including respiratory, skin, and sexually transmitted infections. This antibiotic's effectiveness against a wide range of pathogens has established it as a go-to solution in both hospital and outpatient settings, especially as global incidences of respiratory infections, including pneumonia, remain high.

The prevalence of antimicrobial resistance (AMR) has also influenced azithromycin's market dynamics, with health authorities and pharmaceutical companies promoting its use as an effective alternative in cases where resistance to other antibiotics is prevalent. Additionally, recent outbreaks of infectious diseases have spurred demand, as azithromycin is often included in emergency healthcare protocols. Expanding healthcare infrastructure and increased access to healthcare services in emerging economies further contribute to market growth.

  Azithromycin Industry Analysis

In Q4 2023, the North American azithromycin market faced price volatility influenced by inflation, interest rates, and ongoing geopolitical issues, creating an overall bearish outlook. In the United States, October saw a price dip due to low domestic demand and high inventory levels among suppliers, with a strong dollar facilitating affordable imports and ensuring ample supply. Although signs of inflation easing in November led to a temporary price uptick as consumer spending grew, December witnessed another decline. This was due to a decrease in demand, with the market focused on clearing older stock.

Concurrently, in the APAC region, the market showed varied dynamics, with China experiencing an initial slowdown in October as demand weakened and supplies grew, compounded by reduced manufacturing activities following the early October holidays. By November, however, the market rebounded with increased inquiries from downstream sectors, especially healthcare, as seasonal demand rose, pushing prices slightly higher. Yet, in December, prices dropped again due to declining domestic and international demand, influenced by antibiotic resistance concerns, which led consumers to consider alternative medications, ultimately reducing azithromycin's appeal and impacting its demand.

 Moreover, in Europe, azithromycin prices fluctuated as market conditions shifted. In Germany, October saw a price reduction driven by subdued consumer sentiment, ample supply, and high interest rates, with inflation notably decreasing due to lower fuel costs. November brought a moderate price recovery, supported by a slight increase in demand from the healthcare sector, alongside reduced inventories following a drop in imports from China. However, December's inflation resurgence and continued high interest rates dampened demand from pharmaceutical sectors, pushing prices down as consumers and businesses cut back on spending.

Regional Price Analysis:

  • Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand
  • Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece
  • North America: United States and Canada
  • Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru
  • Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco

Note: The current country list is selective, detailed insights into additional countries can be obtained for clients upon request.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145